Since 2018, Dr. Shinkura has been a professor at the Institute for Quantitative Biosciences (the University of Tokyo, Japan). She graduated from Kyoto University (MD, 1986) and worked as a clinician for six years. She obtained a PhD in 1997 (under Dr. Tasuku Honjo). Then she continued research with Dr. Frederick W. Alt at Harvard Medical School in Boston, USA. In 2003, she rejoined Dr. Honjo's group. In 2010, she established a new laboratory at the Nagahama Institute of Biosciences and Technology, the Nara Institute of Biosciences and Technology, and the present institute. She focuses on IgA drug development as a gut microbial regulator.

Will be updated soon.

Estanislao Nistal Villan got his degree in biochemistry from the University of Salamanca in 2000. In 2001, he joined the Dr. Adolfo Garcia-Sastre laboratory at the Department of Microbiology at the School of Medicine at Mount Sinai Hospital in New York (now the Icahn School of Medicine). His research during this time focused on influenza virulence factors and the development of experimental vaccines in mouse models. He also got involved in the 1918 influenza virus recovery and characterization project. In the fall of 2004, He became a Ph.D. student at Mount Sinai School of Medicine, where he conducted his research in the groups of Dr. Adolfo Garcia Sartre and Dr. Aneel Aggarwal. During this period, he worked on projects related to the structural and transcriptional characterization of type I interferon (IFN) production as well as the regulation of the antiviral response by inducing the innate immune response. He worked on the determination of the structural and biological characteristics of the viral infection sensor RIG-I and on the post-translational modifications that control interferon-β transcription. He defended my doctoral thesis entitled "Molecular and Structural Studies in the Regulation of Interferon-β Production by RNA Virus Infection" in January 2010. Several publications from this period present relevant discoveries about the mechanisms governing viral detection and the mechanisms of IFN induction and antiviral responses. In 2010, he joined the group of Gloria Gonzalez Aseguinolaza at the Department of Gene Therapy of the Center for Medical and Applied Research (CIMA) at the University of Navarra, where he worked on the development of cellular and animal models based on the regulation of IFN type I to stimulate antitumor and antiviral responses. He also collaborated with the groups of Rubén Hernandez Alcoceba and Esther Larrea to study the use of NDV as an oncolytic virus. Together with the group of Tomas Aragon and Gloria Gonzalez, they developed an ER-stress-dependent inducible system to express recombinant proteins in a mouse model upon viral infections. In 2015, he joined the Microbiology Section of the Faculty of Pharmacy of the CEU San Pablo University and worked as a researcher at the Institute of Molecular and Applied Medicine (IMMA). He got accreditation as a full professor from ANECA in 2019. He is responsible for General Microbiology, Microbial Biotechnology, Microbial Genetics, and Virology courses in the degrees of Pharmacy, Biotechnology, Medicine, and Genetics. In parallel, he is the principal investigator of the research group Virology and Innate Immunity (VII). His group works on the characterization of alternative mechanisms to induce interferon expression and antiviral responses.

Will be updated soon

Dr. Lufuno Phophi is a Postdoctoral Fellow with a specialized expertise in microbiology, molecular epidemiology, and antimicrobial resistance of infectious pathogens. Born and raised in South Africa, Dr. Lufuno Phophi developed an early passion for scientific research and public health. This passion led to the completion of a Master of Science in Paraclinical Science focusing on the isolation of coagulase negative staphylococcus species causing mastitis, providing a strong foundation in the understanding of infectious diseases and their impact on human health. In 2019, Dr. Lufuno Phophi relocated to the United States to further their academic and research pursuits, enrolling in a Ph.D. program in Comparative and Experimental Medicine at the University of Tennessee Veterinary College. Their doctoral studies were marked by a rigorous exploration of antimicrobial resistance and molecular epidemiology of Staphylococcus Pseudintermediusin the United States and South Africa which culminated significant contributions to the field of antimicrobial resistance research. In 2022, Dr Lufuno Phophi defended her dissertation and published on “Temporal changes in antibiotic resistance and population structure of methicillin-resistant Staphylococcus pseudintermediusbetween 2010 and 2021 in the United States” as well as “The molecular epidemiology and antimicrobial resistance of Staphylococcus pseudintermedius canine clinical isolates submitted to a veterinary diagnostic laboratory in South Africa.” Currently, Dr. Lufuno Phophi is engaged in advanced postdoctoral research at the University of Florida College of Medicine, Department of molecular genetics and Microbiology. Their research focuses on the critical role of maternal and neonatal microbiota-derived metabolites in regulating neonatal susceptibility to norovirus infection. This work is at the cutting edge of microbiome research, offering valuable insights into how early-life microbial environments influence health outcomes and disease resistance in newborns. Dr. Lufuno Phophi dedication to understanding and combating infectious diseases extends beyond the laboratory. Their research not only contributes to the scientific community but also holds potential implications for public health policies and interventions aimed at reducing the burden of infectious diseases globally. Throughout their career, Dr. Lufuno Phophihas demonstrated a commitment to excellence in research, a passion for discovery, and a profound dedication to improving health outcomes through scientific innovation.

XiaohuaTeng, female, born in March 1963, PH. D, professor, doctoral supervisor, works in the College of Animal Science and Technology, Northeast Agricultural University (Harbin, China).  Her main research interest is "Molecular mechanisms of deleterious effects of environmental stress on organisms and effective ways to mitigate deleterious effects." She once served as the team leader of Livestock and Poultry Environment Discipline" at Northeast Agricultural University and the discipline leader of the key discipline of Heilongjiang Province (China) on "Animal Husbandry System Management." At present, she is one of the "outstanding scholars" at Northeast Agricultural University. She is also an expert in the project evaluation of the National Nature Fund (China), as well as an expert in the evaluation of doctoral and master's theses and an excellent doctoral graduation thesis of the degree center of the Ministry of Education (China). In addition, she serves as a vice president of the "Livestock Ecology Branch of the China Society of Animal Husbandry and Veterinary Medicine," an expert of "the International Cooperation Committee on Animal Welfare of China Association, and an executive director of Heilongjiang Animal Husbandry and Veterinary Society, a member of the Heilongjiang Agricultural Rural Reform and Development Soft Science Research Committee, an evaluation expert of Heilongjiang Educational Science Planning, and an expert of Heilongjiang Educational Science Planning Office in the 12th Five Year Plan and the 13th Five Year Plan. She was a chairman and member of conference academic committee, host of the branch venue, keynote speaker, and invited speaker at many academic conferences. She presided over, guided, and participated in 28 projects of the NSFC and other scientific research topics, and she won 10 scientific research awards. She serves as an editor for Metabolites (SCI, 3-zone of the Chinese Academy of Science (CAS, China), IF = 4.1) and four leading Guest Editor for Special Issue of Metabolites on "The Role of Signaling Pathways in Animal Cell Metabolism", and on "Environmental Pollution and Animal Health: Toxicity and Metabolism", and for Special Issue of Microorganisms (SCI, 3-zone of CAS, IF = 4.5) on "The role of Heat Shock Proteins in Diseases and Their Therapeutic Potential: Environmental stress and Microorganisms", Special Issue of Toxics on "Effects of Environmental Contaminants on Animals: Toxicity and Molecular Mechanism in Toxics" (SCI, 3-zoneof CAS, IF: 4.6), as well as a member of review committee of Animals (SCI, 2-zone of CAS, IF = 3.0). She reviewed manuscripts for eight 1-zones of CAS, twenty-two 2-zones of CAS, forty-four 3-zones of CAS, and seventeen 4-zones of CAS.

Shen Chenguang, a professor at the School of Public Health at Southern Medical University and a renowned youth in Guangdong Province. Focusing on the research field of diagnosis, prevention, and treatment against human viral infectious diseases, 28 SCI papers have been published in JAMA, Science, and other fields as first or corresponding author, with 3 high citations and 1 hot topic, which has been cited 3500 times. He is listed in the world's top 2% of top scientists for 2021 and 2022.

Dr. Bassam Elgamoudi is a molecular microbiologist at Griffith University, Australia. He graduated from the School of Biological Sciences at the University of Leicester, UK, obtained his PhD in 2016, and worked as a postdoctoral fellow at the Institute for Glycomics at Griffith University for over 7 years. Dr. Elgamoudi has expertise in bacterial genetics and host-pathogen interactions. Dr. Elgamoudi was part of the team that published the first characterization of the chemotaxis receptor of Campylobacter jejuni. These publications used a novel high-throughput array methodology for identifying chemotaxis ligands (amino acid and chemotaxis chemical arrays) led to the discovery of a novel chemoreceptor for sugars and a receptor with a broad binding scope. He recently joined the Mucosal Immunology Research Group at Menzies Health Institute Queensland (MHIQ), School of Pharmacy and Health, Australia. His main interest is to investigate the nature of infectious diseases, immunity, and human health and to discover novel approaches and therapeutics to fight infection, inflammation, and autoimmune diseases.

Dr. Xianfeng Zhou is a microbiologist at Jiangxi University of Chinese Medicine, Nanchang, China. He graduated from Hamamatsu University School of Medicine and obtained a PhD in 2019, and worked as researcher in Nanchang Center for Disease Control and Prevention for 3 years. During 2014-2015, he worked as a visiting researcher in National Institute of Infectious Diseases in Tokyo, Japan. He has been working of molecular epidemiology and virology for over 10 years. His major interest of research areas includes molecular epidemiology of acute viral infection, molecular and immunology of cancer viruses such as human polyomavirus and HPV, and traditional Chinese medicine in anti-virus treatment.

Dr Roberto Grau is a biochemist who began his studies in the School of Biochemistry and Pharmacy of Rosario National University (UNR), Rosario-Argentina. He completed his PhD at UNR, studying the regulation of lipid synthesis during cold-shock response and sporulation in the model bacterium Bacillus subtilis. He performed his postdoctoral studies in molecular biology of sporulation in The Scripps Research Institute (TSRI), Department of Experimental and Molecular Medicine at San Diego, California, USA. Roberto has obtained many national and international awards, and finantial funding from goverment agencies and private companies, during his 35 years of research on Bacillus subtilis and other spore-formers. He has published more than 45 original papers in reputed journals, directed dozens of graduate and PhD thesis, formed more than fifty profesional groups in science, visited many universities and reseacrh institutes around the globe (France, Spain, Germany, India, Japan, Brazil, Cuba, Chile, U.S.A., U.K.), founded and/or catalysed the creation of half-dozen biotechnological companies, including Kyojin S.A. He is now a professor of Microbiology in the UNR, Pew Latin American Fellow (San Francisco, USA), a Fulbright International Scholar (Washington DC, USA), and head of the Molecular Biology Laboratory on Spore-Forming Bacteria in Rosario-Argentina.

Dr. Xiaowei Zhang is currently serving as a PI in the Department of Obstetrics and Gynecology at Peking University Shenzhen Hospital in China. With a focus on the research and development of biological therapies for female reproductive tract infections, she has devoted many years to this field. Dr. Zhang has established a comprehensive workflow for high-throughput probiotic screening with a self developed probiotic pathway database. She has successfully identified human-origin Lactobacillus strains that can restore vaginal health in patients recovering from bacterial vaginosis. Dr. Zhang's work also involves explaining the relationship between reprodective tract microbiota and deseases, analyzing vaginal infections using a multi-omics approach, and proposing new clinical grading diagnosis methods based on the results. Additionally, she also serves as a young editorial board member of the AJOG Chinese Edition of Gynecological Infection journal, and has been recognized as a high-level talent in Shenzhen, China.

Prof. Milan Lukas, MD, CSc., AGAF, was born in 1959 in Tábor. He graduated from the 1st Faculty of Medicine, Charles University Prague, in 1984. He passed his board examination in gastroenterology in 1993. From 1993, he worked at the General Teaching Hospital in Prague, at the Clinic of Internal Medicine, specializing in inflammatory bowel disease. He has been the head of the ISCARE clinic since 2007 and he is also the Senior Consultant of the ISACRE Clinical and Research Center for Inflammatory Bowel Disease. Prof. Lukas is the author of more than 250 publications in both Czech and foreign medical journals. He is the past president of the Czech Gastroenterological Society and editor-in-chief of the journal “Gastroenterology and Hepatology.” He is a member of several international organizations, including the American Gastroenterological Association, the European Crohns and Colitis Association, and the International Organization for the Study of Inflammatory Bowel Disease.

Will be updated soon

Consultant in pediatric allergy immunology. Head section of pediatric allergy immunology in King Fahad armed forces hospital, Saudi Arabia

Yoshimi Kubo DDS, PhD I began my allergy prevention work in 2013 based on my own long-term interest in preventing allergies. 2012 Completed Doctoral program (Environmental and Ecological Medicine and Public Health), Graduate School of Medical Science, Kanazawa University, Japan 2012-present Preventive Medicine Instructor 2013-present Cancer Certified Physician 2014-present: Certified Diabetes Educator 2014-2016: Visiting Scientist at the Department of Human Health Science, University of Nagasaki Graduate School 2016-present Postdoctoral Fellow at the Department of Dermatology, Wakayama Medical University 2019: Completed Harvard Medical School ICRT-Japan Program 2021: Completed Harvard Medical School GCSRT Program Awards Atopic Dermatitis Clinical Epidemiological Research Encouragement Award 2016 Best Presentation Award, Japanese Society of Pediatric Dermatology, 2017 Ishikawa Governor's Commendation for Public Health Meritorious Service in Maternal and Child Health Care 2017 Merit Award of the Japanese Dermatological Association 2018 Current Research Interest Since 2016, I have formed a project team on pediatric allergy prevention in collaboration with Harvard Medical School, Dokkyo Medical University Department of Pediatrics, and Wakayama Medical University Department of Dermatology, and I have continued research as a principal investigator. In 2023, I published the first paper in Asia on saliva contact during infancy and allergy development in school-age children. Our new project team is interested in the relationship between oral microbiota and pediatric allergy development, with a further aim to develop new allergy prevention methods during pregnancy and infancy.

Kevin is a microbiology graduate of Texas A&M University. He worked for 30 years at Eli Lilly & Company in the Indianapolis Quality Control Laboratory, developing endotoxin assays. He has authored many papers and several books on Endotoxin Detection and Control including: Endotoxins, 2nd Edition, Endotoxins, 3rd Edition, Contamination Control in Pharmaceutical Manufacturing, and, most recently, Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems (2019).

Dr. Amira Ali is an allergy and clinical immunology specialist with an interest in food allergies, atopic dermatitis, and chronic urticaria. Since graduating from the school of medicine at the University of Bahry in 2007 and enrolling in the master's degree in clinical and laboratory immunology in 2013,. She earned the medical doctorate in clinical immunology from the SUDAN MEDICAL SPECIALIZATION BOARD in 2019. Since then, she has been experienced in the pediatric allergy and immunology departments at King Salman Medical City, Saudi Arabia. She is interested in food allergies and atopic dermatitis and has done research about the relationship between chronic spontaneous urticaria and autoimmune thyroid disorders. She is a member of the EAACI and APAACI societies and was recently a member of the SAAIS societies.

Dr. Yanfei Yang is a medical graduate student in the Department of General Surgery of the First Affiliated Hospital of Dalian Medical University, China. He is deeply interested in the immune escape of intestinal flora and CRC, and has published a review article on intestinal flora, CRC, and immunity in related journals as the corresponding author. And he has published several articles on clinical medicine as the first author in the Annals of Surgical Oncology and the Annals of Surgery. He also has an interest in intestinal flora and tumor immunity and is happy to share his relevant ideas with you.

Dr.Maria de la Caridad Montalvo Villalba is a medical doctor with a background in virology and immunology, currently working as a senior researcher at the National Reference Laboratory for Viral Hepatitis at IPK. She has expertise in serological and molecular diagnostics, next generation sequencing and epidemiology of viral infectious diseases. Dr. Montalvo Villalba also has experience in the evaluation of immune responses to vaccines (Hepatitis B and COVID-19 vaccines), cytokine gene polymorphism studies, and evaluation of health programs related to viral hepatitis. She has published more than 45 research papers and is on the editorial boards of international and national scientific journals. Her results have been recognized by the Cuban Academy of Sciences and the National Health System. Dr. Montalvo Villalba is Professor of Virology and Immunology for undergraduate and postgraduate students at the IPK and the High School of Medicine in Havana. Her areas of interest are focused on accurate diagnosis of viral diseases, monitoring of correlates of immunity in vaccine,molecular epidemiology of hepatitis viruses and immunopathogenesis.